Mes collègues Chelsea Nimmo, Kristin Wall et Judith Robinson ont fait rapport de la sanction royale du projet de loi C-30 qui mettra en Suvre les dispositions de l’Accord économique et commercial global (AECG).
Parmi ces dispositions, il y a des réformes de la Loi sur les brevets qui affecteront l'industrie pharmaceutique, dont :
- le rétablissement de la durée des brevets;
- le remplacement des procédures sommaires en vertu du Règlement sur les médicaments brevetés (avis de conformité) par des actions qui fourniront une décision finale de contrefaçon et de validité;
- et un droit d'appel pour les innovateurs.
Grâce à la sanction royale, la mise en Suvre de la loi est une question de semaines. À suivre…
About Norton Rose Fulbright Canada LLP
Norton Rose Fulbright is a global law firm. We provide the world's preeminent corporations and financial institutions with a full business law service. We have 3800 lawyers and other legal staff based in more than 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.
Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.
Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.
For more information about Norton Rose Fulbright, see nortonrosefulbright.com/legal-notices.
Law around the world
nortonrosefulbright.com
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
